Clinical Trial Update: Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating on belatacept-based immunosuppression versus standard regimens in kidney transplant patients, with a focus on new-onset diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• New-onset Diabetes After Transplantation

Drugs mentioned

• Nulojix (belatacept)

Snippet

Sponsor: University of Arizona | Conditions: New Onset Diabetes After Transplant, Kidney Transplantation | Phase 4 | Status: UNKNOWN